These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28978465)

  • 1. Sarm1 Deletion, but Not Wld
    Gilley J; Ribchester RR; Coleman MP
    Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
    White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
    Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
    Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
    Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
    Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
    Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.
    Loring HS; Thompson PR
    Cell Chem Biol; 2020 Jan; 27(1):1-13. PubMed ID: 31761689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
    Conforti L; Gilley J; Coleman MP
    Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed axon degeneration: from mouse to mechanism to medicine.
    Coleman MP; Höke A
    Nat Rev Neurosci; 2020 Apr; 21(4):183-196. PubMed ID: 32152523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
    Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
    Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.
    Loreto A; Di Stefano M; Gering M; Conforti L
    Cell Rep; 2015 Dec; 13(11):2539-2552. PubMed ID: 26686637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
    Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
    J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against oxaliplatin-induced mechanical and thermal hypersensitivity in Sarm1
    Gould SA; White M; Wilbrey AL; Pór E; Coleman MP; Adalbert R
    Exp Neurol; 2021 Apr; 338():113607. PubMed ID: 33460644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
    Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.